Differential Diagnosis for Abnormal Pap Smear Cells
Abnormal Pap smear cells are categorized using the Bethesda System into squamous cell abnormalities (ASC-US, ASC-H, LSIL, HSIL) and glandular cell abnormalities (AGC, AIS), with the differential diagnosis ranging from benign reactive changes to invasive carcinoma.
Squamous Cell Abnormalities
ASC-US (Atypical Squamous Cells of Undetermined Significance)
- Most common abnormality (~4% of all Pap smears) 1
- Differential includes:
- Reactive/inflammatory changes (most common)
- HPV infection
- CIN 1 (low-grade dysplasia)
- CIN 2,3 (9.7% risk of CIN 2 or worse) 1
- Rarely invasive carcinoma
ASC-H (Atypical Squamous Cells - Cannot Exclude HSIL)
- High-risk category with up to 50% prevalence of CIN 2,3 1
- Differential includes:
- CIN 2,3 (most likely)
- HSIL
- Invasive squamous cell carcinoma
- Reactive changes mimicking high-grade lesions
LSIL (Low-Grade Squamous Intraepithelial Lesion)
- Differential includes:
HSIL (High-Grade Squamous Intraepithelial Lesion)
- Differential includes:
- CIN 2,3 (most common)
- Carcinoma in situ
- Early invasive squamous cell carcinoma
- Small cell morphology variant (important pitfall) 2
Glandular Cell Abnormalities (AGC)
AGC-NOS (Not Otherwise Specified) and AGC-Favor Neoplasia
These carry significant risk and require comprehensive workup including colposcopy with endocervical sampling 3. The differential includes:
Benign/Reactive Conditions:
- Reactive endocervical cells (inflammatory changes)
- Tubal metaplasia
- Endometriosis
- Microglandular hyperplasia
- Arias-Stella reaction (pregnancy-related)
Preneoplastic/Neoplastic Lesions:
- Endocervical adenocarcinoma in situ (AIS)
- Invasive endocervical adenocarcinoma
- Adenoma malignum (minimal deviation adenocarcinoma - critical pitfall as it can be called benign) 2
- Endometrial adenocarcinoma (especially in women ≥35 years) 3
- Endometrial hyperplasia
Rare but Important Entities
The following uncommon diagnoses can present as abnormal Pap cells and represent critical diagnostic pitfalls 2:
Neuroendocrine Tumors:
- Small cell carcinoma
- Large cell neuroendocrine carcinoma
Other Rare Primary Tumors:
- Glassy cell carcinoma
- Clear cell carcinoma
- Malignant mixed Müllerian tumor
- Primary malignant melanoma
Metastatic Disease:
- Lung cancer 4
- Breast cancer
- Gastrointestinal malignancies
- Ovarian cancer
Hematologic Malignancies:
- Non-Hodgkin lymphoma (diffuse large B-cell most common) 5
- Acute myeloid leukemia
- Extraosseous plasmacytoma
Infectious Mimics:
These can be misdiagnosed as malignancy 6:
- Tuberculosis cervicitis (can mimic carcinoma)
- Granuloma inguinale
- Coccidioidomycosis
- Schistosomiasis (associated with squamous cell carcinoma)
- Molluscum contagiosum
Age-Specific Considerations
Premenopausal Women:
- Benign-appearing endometrial cells rarely associated with significant pathology 3
- Endometrial stromal cells/histiocytes usually have no clinical significance 3
Postmenopausal Women:
- Benign-appearing endometrial cells frequently associated with significant endometrial pathology (even on hormone replacement therapy) 3
- AGC requires endometrial sampling in women ≥35 years 3
- AGUS in postmenopausal women signifies underlying pathology requiring investigation 7
Critical Diagnostic Pitfalls
Key distinguishing cytomorphologic features between neoplastic and benign lesions include 8:
- Dissociated atypical cells
- Nuclear membrane irregularity
- Architectural pattern disruption
- Chromatin pattern abnormalities
Common misdiagnoses to avoid: